Axon Gains Institutional Support Amid 387th Trading Rank

Axon Enterprise (AXON) closed on September 5, 2025, with a 0.24% decline to $727.00, trading on a volume of $290 million, ranking 387th in market activity. The stock remains underpinned by robust institutional interest, with 11 Capital Partners LP increasing its stake by 33% in Q1, now holding 14,900 shares valued at $7.8 million. This move followed broader institutional buying, including 0.8% gains by WCM Investment Management and 5.1% growth in holdings by Smartleaf Asset Management. Collectively, institutional investors control 79.08% of AXON shares.

Analyst sentiment has sharpened, with 13 firms upgrading the stock to “Buy” or “Overweight” in recent months. Bank of America raised its price target to $1,000, while Morgan Stanley and Craig Hallum set $885 and $900 goals, respectively. The stock’s average consensus target now stands at $837.69, reflecting confidence in its 32.6% year-over-year revenue growth reported in Q2. However, insider transactions revealed mixed signals, including a 0.33% stake reduction by CEO Patrick Smith and a 5.18% cut by Jeffrey Kunins, though insider ownership remains at 5.7%.

To build this back-test accurately I need to clarify a few practical details: 1. Universe • Should we include all U.S. common stocks listed on NYSE + NASDAQ + AMEX (i.e., ≈ 5 000 tickers), or do you want to confine the test to a predefined index set such as the Russell 3000 or S&P 500 constituents? 2. Trade-timing convention • Buy price: open or close of the ranking day? • Sell price (after holding one day): next day’s open or close? 3. Rebalancing costs • Do you want to include transaction costs or slippage (e.g., 2 bps per side) when 500 positions turn over daily? 4. Capital allocation • Equal-weight each of the 500 stocks daily, or weight by something else (e.g., volume-weighted, dollar-neutral)?